World leader in MDI Canisters, Actuators & Dispensers

Global provider of medical drug-delivery devices and components to the pharmaceutical sector

H&T Presspart is a world leader and specialist in manufacturing drug-delivery systems and pharmaceutical components. The solutions we offer our pharmaceutical clients include metered-dose inhaler canisters and components, and a comprehensive range of dose-counting technologies.

We offer more than 45 years’ experience of meeting the needs of the world’s leading pharma companies. During that time we’ve developed a strong reputation for precision and reliability, critically important when patients’ quality of life can depend on the tiniest of details, both in the medication and its delivery system. Our extensive skills and experience as medical device manufacturers cover every aspect of deep-drawn manufacturing and injection moulding for the pharmaceutical industry.

As healthcare and pharmaceutical knowledge and understanding continue to evolve, so do we. We focus on industry-leading innovations, continually pushing the boundaries to find technologies that will improve drug delivery performance for our customers and their patients. You can use our advice, support and experience to help you make the best decisions early in the product and device development process.

Plasma

H&T Presspart has developed a revolutionary sub-micron plasma technology process for treating the internal surface of metered-dose inhaler canisters. The H&T Presspart plasma treatment process improves the surface energy properties of an MDI canister, thus helping to prevent the active content of a drug formulation adhering to the canister wall.

Quantum

Our off-the-shelf Quantum ™® dose indicator is the very first on-can end-of-life solution, ensuring patients don’t run out of their medication. It’s cost-effective, disposable, and simple to use – and, as it includes no mechanical parts, it’s extremely reliable.

eMDI

H&T Presspart and Cohero Health have developed the first market-ready, fully embedded and connected metered-dose inhaler (MDI). By tracking and recording data on the use of medications, and sharing it with patients and physicians via a mobile or web app, the eMDI ™ enables pharmaceutical manufacturers to bring the best possible care to those with asthma and COPD.

Mechanical Dose Counter

Asthma and COPD are conditions that need constant monitoring and controlling. So methods for predicting the end of life of metered-dose inhalers can improve patient safety and quality of life, as well as reduce hospital admissions.

Our State Of The Art Facilities

Our three European manufacturing sites produce over 75% of the world’s metered-dose inhaler components. Our facilities also include the brand new state of the art Inhalation Product Technology Centre (IPTC).

Our Innovation

H&T Presspart is at the cutting edge of drug delivery device design and manufacture. The drug delivery devices we help to create are some of the most innovative & reliable on the market. We strive to stay ahead of the changes within the pharmaceutical market to ensure we are always able to offer the right solution for your needs.

Our Partners

Our partners are the world leaders within the pharmaceutical industry for respiratory drug delivery solutions. Our proven knowledge and expertise in the drug delivery market makes us the partner of choice for the industry.

Our Locations

H&T Presspart has three European manufacturing sites in the UK, Germany & Spain. Committed to supporting our regional customers, H&T Presspart also has sales office based in Singapore, India, Uruguay & the USA.

Our Talent

As a market leader in our field, H&T Presspart employees people from a wide range of career and skill backgrounds. H&T Presspart invests heavily in the training and education of employees with major specialised training programmes, including a long-established Apprenticeship scheme

We've a number of career opportunities at our manufacturing sites in Tarragona, Spain and Marsberg, Germany currently available. If you would like to learn more about @Presspart and these roles please visit our website presspart.com/careers/
16 hours ago